David Barocio's Contact Details

David Barocio's Company Details

Genelex Corporation

Seattle, WA, US • 20 - 49 Employees
BioTech/Drugs

Founded in 1987, Genelex is a highly accredited leader in precision medication management and one of the first clinical laboratories to provide pharmacogenetic testing and interpretation as creator of YouScript - a patented, proprietary and powerful clinical decision support tool. Genelex pharmacogenetic tests reveal natural variations that determine how the body processes commonly prescribed medications. More than 90% of the population have genetic variations that determine how their bodies process drugs. This applies to both prescription and over-the-counter medications. Due to these genetic differences, two people can take the same dose of the same drug but respond in very different ways. Each year in the United States, 8.6 million dangerous adverse drug events occur, resulting in more than 100,000 deaths. The FDA estimates the cost at a minimum of $30 billion per year. Our expert staff and state-of-the-art laboratory are focused and driven to prevent drug-gene and drug-drug interactions, especially in patients with significant polypharmacy who are at most risk. Genelex is one of the longest-running leaders pharmacogenetics. We work diligently to help polypharmacy patients and physicians improve medication outcomes with pharmacogenetic testing and offer both clinical and research level PGx testing to CRO's and pharmaceutical companies helping to ensure safer drugs to market. We look forward daily to our role in making pharmacogenetics a commonplace term in every physician's office and kitchen table across the United States.